LGND
Ligand Pharmaceuticals Incorporated
$170.77
+$4.26(+2.56%)
72
Overall
--
Value
72
Tech
--
Quality
Market Cap
$3.26B
Volume
256.77K
52W Range
$93.58 - $170.78
Target Price
$184.29
EPS Estimates Overview
| Current Quarter | $1.08 | Next Quarter | $1.08 |
| Current Year | $0.31 | Next Year | $4.66 |
| QoQ Growth | +0.0% | YoY Growth | +1403.2% |
| 3Y EPS CAGR | -28.1% | Target Price | $184.29 |
| Consensus | Buy | Upside | +7.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $170.77 | +2.6% | 256.77K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW